Physician_Profile_ID,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Form_of_Payment_or_Transfer_of_Value,Record_ID,Nature_of_Payment_or_Transfer_of_Value,Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value,Name_of_Associated_Covered_Drug_or_Biological1,Name_of_Associated_Covered_Drug_or_Biological2,Contextual_Information
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3750,09/16/2014,"Cash or cash equivalent",149200220,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"","Speaker Fee"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3700,12/04/2014,"Cash or cash equivalent",150117600,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"","Speaker Fee"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3700,04/23/2014,"Cash or cash equivalent",149960487,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"","Speaker Fee"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3700,12/01/2014,"Cash or cash equivalent",150407003,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"","Speaker Fee"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3250,08/19/2014,"Cash or cash equivalent",150908988,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"","Speaker Fee"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3250,01/06/2014,"Cash or cash equivalent",148704442,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"","Speaker Fee"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3250,04/23/2014,"Cash or cash equivalent",148427542,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"","Speaker Fee"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3250,10/12/2014,"Cash or cash equivalent",149412497,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"","Speaker Fee"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3250,11/09/2014,"Cash or cash equivalent",148424842,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"","Speaker Fee"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3250,10/26/2014,"Cash or cash equivalent",150020590,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"","Speaker Fee"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3250,02/12/2014,"Cash or cash equivalent",150778134,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"","Speaker Fee"
46454,"Novo Nordisk Inc",NJ,100000000144,2800.00,12/11/2013,"Cash or cash equivalent",221922120,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"","Fair market value compensation to speak, educate, and provide healthcare providers and patients with balanced scientific and clinical information regarding disease state and Novo Nordisk products."
46454,"Novo Nordisk Inc",NJ,100000000144,2800.00,09/18/2013,"Cash or cash equivalent",221949840,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Levemir,"","Fair market value compensation to speak, educate, and provide healthcare providers and patients with balanced scientific and clinical information regarding disease state and Novo Nordisk products."
46454,"Novo Nordisk Inc",NJ,100000000144,2800,11/13/2014,"Cash or cash equivalent",160635562,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,2800,10/16/2014,"Cash or cash equivalent",160631834,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,2800,03/14/2014,"Cash or cash equivalent",160620900,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Levemir,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,2550.00,10/11/2013,"Cash or cash equivalent",221936742,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"","Fair market value compensation to speak, educate, and provide healthcare providers and patients with balanced scientific and clinical information regarding disease state and Novo Nordisk products."
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,2260,03/15/2014,"Cash or cash equivalent",188484646,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","","","",""
46454,"Novo Nordisk Inc",NJ,100000000144,2050.00,11/25/2013,"Cash or cash equivalent",221920204,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"","Fair market value compensation to speak, educate, and provide healthcare providers and patients with balanced scientific and clinical information regarding disease state and Novo Nordisk products."
46454,"Novo Nordisk Inc",NJ,100000000144,2050.00,11/14/2013,"Cash or cash equivalent",221906138,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"","Fair market value compensation to speak, educate, and provide healthcare providers and patients with balanced scientific and clinical information regarding disease state and Novo Nordisk products."
46454,"Novo Nordisk Inc",NJ,100000000144,2050.00,10/22/2013,"Cash or cash equivalent",221921362,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"","Fair market value compensation to speak, educate, and provide healthcare providers and patients with balanced scientific and clinical information regarding disease state and Novo Nordisk products."
46454,"Novo Nordisk Inc",NJ,100000000144,2050.00,12/06/2013,"Cash or cash equivalent",221934494,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"","Fair market value compensation to speak, educate, and provide healthcare providers and patients with balanced scientific and clinical information regarding disease state and Novo Nordisk products."
46454,"Novo Nordisk Inc",NJ,100000000144,2050.00,10/17/2013,"Cash or cash equivalent",221951634,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"","Fair market value compensation to speak, educate, and provide healthcare providers and patients with balanced scientific and clinical information regarding disease state and Novo Nordisk products."
46454,"Novo Nordisk Inc",NJ,100000000144,2050.00,08/09/2013,"Cash or cash equivalent",221950290,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"","Fair market value compensation to speak, educate, and provide healthcare providers and patients with balanced scientific and clinical information regarding disease state and Novo Nordisk products."
46454,"Novo Nordisk Inc",NJ,100000000144,2050,10/30/2014,"Cash or cash equivalent",160620922,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Levemir,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,2050,02/08/2014,"Cash or cash equivalent",160620918,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Levemir,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,2050,11/18/2014,"Cash or cash equivalent",160624758,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,2050,09/09/2014,"Cash or cash equivalent",160620932,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,2050,12/12/2014,"Cash or cash equivalent",160635558,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,2050,06/27/2014,"Cash or cash equivalent",160620928,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,2050,06/20/2014,"Cash or cash equivalent",160620904,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",NovoLog,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,2050,04/24/2014,"Cash or cash equivalent",160624750,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Levemir,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,2050,03/07/2014,"Cash or cash equivalent",160621076,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,2050,12/02/2014,"Cash or cash equivalent",160624754,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,2050,07/29/2014,"Cash or cash equivalent",160620924,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,2050,03/14/2014,"Cash or cash equivalent",160620936,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,2050,04/09/2014,"Cash or cash equivalent",160620908,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",NovoLog,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,2050,04/17/2014,"Cash or cash equivalent",160620916,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Levemir,"",""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,1910,03/28/2014,"Cash or cash equivalent",188458104,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",APIDRA,LANTUS,""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1850,10/12/2014,"Cash or cash equivalent",148278422,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"","Speaker Fee"
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,1760,05/28/2014,"Cash or cash equivalent",188464892,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",APIDRA,LANTUS,""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1700,02/24/2014,"Cash or cash equivalent",148601656,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"","Speaker Fee"
46454,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,1595,08/06/2014,"Cash or cash equivalent",194224304,"Consulting Fee","",Oseni,Kazano,""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,1500.00,11/13/2013,"Cash or cash equivalent",14240843,"Consulting Fee","","","",""
46454,"Novo Nordisk Inc",NJ,100000000144,1500.00,08/07/2013,"Cash or cash equivalent",221879798,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"","Fair market value compensation to speak, educate, and provide healthcare providers and patients with balanced scientific and clinical information regarding disease state and Novo Nordisk products."
46454,"Novo Nordisk Inc",NJ,100000000144,1500,09/18/2014,"Cash or cash equivalent",160620912,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",NovoLog,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,1500,12/03/2014,"Cash or cash equivalent",160625928,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1400,10/07/2014,"Cash or cash equivalent",150543426,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"","Speaker Fee"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1400,11/26/2014,"Cash or cash equivalent",148201894,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"","Speaker Fee"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1400,10/12/2014,"Cash or cash equivalent",149411740,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"","Speaker Fee"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1400,11/06/2014,"Cash or cash equivalent",148536478,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"","Speaker Fee"
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,1300.00,11/20/2013,"Cash or cash equivalent",13958780,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"",""
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,1300.00,10/30/2013,"Cash or cash equivalent",13958782,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"",""
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,1300.00,12/13/2013,"Cash or cash equivalent",13958781,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1300,04/22/2014,"Cash or cash equivalent",149880890,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",FARXIGA,"","Speaker Fee"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1300,04/10/2014,"Cash or cash equivalent",148562628,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"","Speaker Fee"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1300,02/19/2014,"Cash or cash equivalent",149225828,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"","Speaker Fee"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1300,03/05/2014,"Cash or cash equivalent",149985138,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",FARXIGA,"","Speaker Fee"
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,1300,01/22/2014,"Cash or cash equivalent",187735020,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1300,03/26/2014,"Cash or cash equivalent",149067368,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",FARXIGA,"","Speaker Fee"
46454,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,1250.00,11/12/2013,"Cash or cash equivalent",103297068,"Consulting Fee","",Oseni,Kazano,""
46454,"Novo Nordisk Inc",NJ,100000000144,1200.00,12/11/2013,"Cash or cash equivalent",221922114,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"","Fair market value compensation to speak, educate, and provide healthcare providers and patients with balanced scientific and clinical information regarding disease state and Novo Nordisk products."
46454,"Takeda Pharmaceuticals U.S.A., Inc.",IL,100000000337,1150,05/16/2014,"Cash or cash equivalent",194224236,"Consulting Fee","",Nesina,"",""
46454,"Takeda Pharmaceuticals U.S.A., Inc.",IL,100000000337,997.05,04/25/2014,"In-kind items and services",194224228,"Travel and Lodging","",Nesina,"",""
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,975.00,10/30/2013,"Cash or cash equivalent",13958779,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","","","",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,975,03/26/2014,"Cash or cash equivalent",148635679,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",FARXIGA,"","Speaker Fee"
46454,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,950.00,08/16/2013,"Cash or cash equivalent",103297062,"Consulting Fee","",Oseni,Kazano,""
46454,"Novo Nordisk Inc",NJ,100000000144,900.00,12/06/2013,"Cash or cash equivalent",221922158,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"","Fair market value compensation to speak, educate, and provide healthcare providers and patients with balanced scientific and clinical information regarding disease state and Novo Nordisk products."
46454,"Novo Nordisk Inc",NJ,100000000144,900,11/13/2014,"Cash or cash equivalent",160626616,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,808.80,10/12/2013,"In-kind items and services",221936740,"Travel and Lodging","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,680.00,10/12/2013,"Cash or cash equivalent",221936744,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Victoza,"","Fair market value compensation to speak, educate, and provide healthcare providers and patients with balanced scientific and clinical information regarding disease state and Novo Nordisk products."
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,650.00,10/24/2013,"Cash or cash equivalent",13958778,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"",""
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,650.00,10/24/2013,"Cash or cash equivalent",13958783,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,608.32,01/25/2014,"In-kind items and services",149613722,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"Novo Nordisk Inc",NJ,100000000144,534.33,10/12/2013,"In-kind items and services",221935176,"Food and Beverage","",Victoza,"",""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,480,06/24/2014,"Cash or cash equivalent",188465458,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",APIDRA,LANTUS,""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,480,07/30/2014,"Cash or cash equivalent",188466400,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",APIDRA,LANTUS,""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,475.56,08/15/2014,"In-kind items and services",150783862,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,463.28,08/15/2014,"In-kind items and services",150328718,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,416.9,03/15/2014,"Cash or cash equivalent",188451390,"Travel and Lodging","","","",""
46454,"Novo Nordisk Inc",NJ,100000000144,339.36,10/16/2014,"In-kind items and services",160631840,"Travel and Lodging","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,335.26,10/12/2013,"In-kind items and services",221936746,"Travel and Lodging","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,325.00,10/12/2013,"In-kind items and services",221936748,"Travel and Lodging","",Victoza,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,313.04,03/26/2014,"In-kind items and services",149811180,"Travel and Lodging","",FARXIGA,"","Speaker Expenses"
46454,"Novo Nordisk Inc",NJ,100000000144,305.67,12/11/2013,"In-kind items and services",221922156,"Travel and Lodging","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,305.10,09/18/2013,"In-kind items and services",221949842,"Travel and Lodging","",Levemir,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,301.28,11/13/2014,"In-kind items and services",160635570,"Travel and Lodging","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,291.2,03/07/2014,"In-kind items and services",160621108,"Travel and Lodging","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,271.20,12/06/2013,"In-kind items and services",221922124,"Travel and Lodging","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,261.52,03/14/2014,"In-kind items and services",160621106,"Travel and Lodging","",Victoza,"",""
46454,"Takeda Pharmaceuticals U.S.A., Inc.",IL,100000000337,250.00,08/27/2013,"Cash or cash equivalent",103297070,"Consulting Fee","",Kazano,Oseni,""
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,250.00,10/29/2013,"Cash or cash equivalent",14061167,"Consulting Fee","",SYMLIN,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,250,12/18/2014,"Cash or cash equivalent",150703386,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BYDUREON,"","Speaker Fee"
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,213.88,01/22/2014,"Cash or cash equivalent",187737228,"Food and Beverage","",BYDUREON,"",""
46454,"Takeda Pharmaceuticals U.S.A., Inc.",IL,100000000337,200.48,04/25/2014,"In-kind items and services",194224254,"Travel and Lodging","",Nesina,"",""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,199.72,03/15/2014,"In-kind items and services",188484644,"Food and Beverage","","","",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,192.88,01/25/2014,"In-kind items and services",149790992,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,179.26,03/15/2014,"In-kind items and services",188451386,"Travel and Lodging","","","",""
46454,"Takeda Pharmaceuticals U.S.A., Inc.",IL,100000000337,165.09,04/26/2014,"In-kind items and services",194224244,"Food and Beverage","",Nesina,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,163.92,04/17/2014,"In-kind items and services",160621090,"Travel and Lodging","",Levemir,"",""
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,163.85,10/30/2013,"Cash or cash equivalent",13958793,"Travel and Lodging","",BYDUREON,"",""
46454,"Takeda Pharmaceuticals U.S.A., Inc.",IL,100000000337,163.44,05/29/2014,"Cash or cash equivalent",194224220,"Travel and Lodging","",Nesina,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,156.24,06/27/2014,"In-kind items and services",160621102,"Travel and Lodging","",Victoza,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,155.26,11/12/2014,"In-kind items and services",150627406,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"Novo Nordisk Inc",NJ,100000000144,151.76,11/18/2014,"In-kind items and services",160624766,"Travel and Lodging","",Victoza,"",""
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,145.21,11/20/2013,"Cash or cash equivalent",13958790,"Travel and Lodging","",BYDUREON,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,144.64,12/18/2013,"In-kind items and services",174051114,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"Novo Nordisk Inc",NJ,100000000144,142.61,10/16/2014,"In-kind items and services",160631836,"Travel and Lodging","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,140.56,06/20/2014,"In-kind items and services",160621080,"Travel and Lodging","",NovoLog,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,137.45,01/25/2014,"In-kind items and services",149800230,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,136.64,04/09/2014,"In-kind items and services",148380854,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,136.17,12/13/2013,"Cash or cash equivalent",13958792,"Travel and Lodging","",BYDUREON,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,127.68,02/08/2014,"In-kind items and services",160621094,"Travel and Lodging","",Levemir,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,127.36,08/15/2014,"In-kind items and services",150867426,"Food and Beverage","",BYDUREON,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,127.34,08/15/2014,"In-kind items and services",150787960,"Food and Beverage","",BYDUREON,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,126.56,01/29/2014,"In-kind items and services",148504646,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,123.76,11/12/2014,"In-kind items and services",150189834,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,122.64,09/17/2014,"In-kind items and services",149606556,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,120.96,09/17/2014,"In-kind items and services",150917786,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,106.4,02/19/2014,"In-kind items and services",150721900,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"Novo Nordisk Inc",NJ,100000000144,104.16,12/02/2014,"In-kind items and services",160624764,"Travel and Lodging","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,104.16,04/24/2014,"In-kind items and services",160624760,"Travel and Lodging","",Levemir,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,101.70,10/17/2013,"In-kind items and services",221951636,"Travel and Lodging","",Victoza,"",""
46454,"Takeda Pharmaceuticals U.S.A., Inc.",IL,100000000337,101.25,04/25/2014,"In-kind items and services",194224260,"Food and Beverage","",Nesina,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,99,11/13/2014,"In-kind items and services",162374934,"Food and Beverage","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,98.39,04/17/2014,"In-kind items and services",162202204,"Food and Beverage","",Levemir,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,97.75,11/14/2013,"In-kind items and services",221906140,"Travel and Lodging","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,97.75,12/06/2013,"In-kind items and services",221934386,"Food and Beverage","",Victoza,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,97.67,04/09/2014,"In-kind items and services",149191208,"Food and Beverage","",BYDUREON,"","Speaker Expenses"
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,96.32,01/22/2014,"Cash or cash equivalent",187737248,"Travel and Lodging","",BYDUREON,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,95.56,03/26/2014,"In-kind items and services",148780114,"Food and Beverage","",FARXIGA,"","Educational Program"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,95.23,01/25/2014,"In-kind items and services",149689666,"Food and Beverage","",BYDUREON,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,95.2,03/05/2014,"In-kind items and services",150297852,"Travel and Lodging","",FARXIGA,"","Speaker Expenses"
46454,"Novo Nordisk Inc",NJ,100000000144,90.72,10/30/2014,"In-kind items and services",160621096,"Travel and Lodging","",Levemir,"",""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,90.16,03/28/2014,"Cash or cash equivalent",188413482,"Travel and Lodging","",LANTUS,APIDRA,""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,89.04,04/10/2014,"In-kind items and services",149058244,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,89.04,10/29/2014,"In-kind items and services",150608301,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,88.48,11/19/2014,"In-kind items and services",150267388,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"Novo Nordisk Inc",NJ,100000000144,84.00,12/11/2013,"In-kind items and services",221922116,"Food and Beverage","",Victoza,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,84,04/10/2014,"In-kind items and services",148745320,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"Novo Nordisk Inc",NJ,100000000144,84,04/09/2014,"In-kind items and services",160621083,"Travel and Lodging","",NovoLog,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,83.85,10/16/2014,"In-kind items and services",162393142,"Food and Beverage","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,82.65,02/08/2014,"In-kind items and services",160809680,"Food and Beverage","",Levemir,"",""
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,79.38,10/30/2013,"Cash or cash equivalent",13958787,"Food and Beverage","","","",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,78.75,11/12/2014,"In-kind items and services",148644044,"Food and Beverage","",BYDUREON,"","Speaker Expenses"
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,78.4,03/15/2014,"Cash or cash equivalent",188451388,"Travel and Lodging","","","",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,77.28,11/19/2014,"In-kind items and services",148187328,"Food and Beverage","",BYDUREON,"","Speaker Expenses"
46454,"Novo Nordisk Inc",NJ,100000000144,76.73,12/03/2014,"In-kind items and services",162287152,"Food and Beverage","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,76.28,11/25/2013,"In-kind items and services",221920330,"Travel and Lodging","",Victoza,"",""
46454,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,73.92,08/06/2014,"Cash or cash equivalent",194224290,"Travel and Lodging","",Nesina,Oseni,""
46454,"Novo Nordisk Inc",NJ,100000000144,72.57,11/18/2014,"In-kind items and services",162310614,"Food and Beverage","",Victoza,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,68.5,03/05/2014,"In-kind items and services",149810160,"Food and Beverage","",FARXIGA,"","Educational Program"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,66.97,10/08/2014,"In-kind items and services",148434676,"Food and Beverage","",BYDUREON,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,66.08,08/15/2014,"In-kind items and services",150746864,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,62.72,10/16/2014,"In-kind items and services",150037402,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"Novo Nordisk Inc",NJ,100000000144,61.22,10/30/2014,"In-kind items and services",162182068,"Food and Beverage","",Levemir,"",""
46454,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,58.76,11/12/2013,"Cash or cash equivalent",103297066,"Travel and Lodging","",Oseni,Kazano,""
46454,"Novo Nordisk Inc",NJ,100000000144,58.37,09/18/2014,"In-kind items and services",162049850,"Food and Beverage","",NovoLog,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,58.24,12/12/2014,"In-kind items and services",160635566,"Travel and Lodging","",Victoza,"",""
46454,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,57.63,08/16/2013,"Cash or cash equivalent",103297060,"Travel and Lodging","",Oseni,Kazano,""
46454,"Novo Nordisk Inc",NJ,100000000144,56.14,11/14/2013,"In-kind items and services",221905146,"Food and Beverage","",Victoza,"",""
46454,"GlaxoSmithKline, LLC.",NC,100000005449,49.12,11/11/2014,"In-kind items and services",198760666,"Food and Beverage","",TANZEUM,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,47.35,04/22/2014,"In-kind items and services",148348280,"Food and Beverage","",FARXIGA,"","Educational Program"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,44.6,08/15/2014,"In-kind items and services",149051792,"Food and Beverage","",BYDUREON,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,44.46,08/15/2014,"In-kind items and services",148858528,"Food and Beverage","",BYDUREON,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,43.15,08/15/2014,"In-kind items and services",150626144,"Food and Beverage","",BYDUREON,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,43.15,08/15/2014,"In-kind items and services",150787516,"Food and Beverage","",BYDUREON,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,42.56,01/25/2014,"In-kind items and services",149692030,"Food and Beverage","",BYDUREON,"","Speaker Expenses"
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,40.12,10/30/2013,"Cash or cash equivalent",13958791,"Travel and Lodging","","","",""
46454,"AbbVie, Inc.",IL,100000000204,39.04,09/24/2013,"In-kind items and services",104615880,"Food and Beverage","",Synthroid,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,38.89,09/18/2013,"In-kind items and services",221949686,"Food and Beverage","",Levemir,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,38.21,01/25/2014,"In-kind items and services",149678664,"Food and Beverage","",BYDUREON,"","Speaker Expenses"
46454,"Novo Nordisk Inc",NJ,100000000144,38.08,07/29/2014,"In-kind items and services",160621100,"Travel and Lodging","",Victoza,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,38.08,10/16/2014,"In-kind items and services",150037280,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"Novo Nordisk Inc",NJ,100000000144,37.29,08/09/2013,"In-kind items and services",221950292,"Travel and Lodging","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,36.16,10/22/2013,"In-kind items and services",221921366,"Travel and Lodging","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,36.12,10/17/2013,"In-kind items and services",221951632,"Food and Beverage","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,32.46,06/13/2014,"In-kind items and services",161843874,"Food and Beverage","",Victoza,"",""
46454,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,32.12,12/22/2014,"In-kind items and services",196367320,"Food and Beverage","",JARDIANCE,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,31.5,02/03/2014,"In-kind items and services",160607028,Education,"",NovoLog,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,29.68,11/19/2014,"In-kind items and services",150268646,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,28.99,01/25/2014,"In-kind items and services",149174076,"Food and Beverage","",BYDUREON,"","Speaker Expenses"
46454,"Novo Nordisk Inc",NJ,100000000144,26.74,10/16/2014,"In-kind items and services",160632026,"Travel and Lodging","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,26.56,12/06/2013,"In-kind items and services",221934388,"Travel and Lodging","",Victoza,"",""
46454,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,25.83,11/12/2013,"In-kind items and services",103297064,"Food and Beverage","",Oseni,Kazano,""
46454,"Novo Nordisk Inc",NJ,100000000144,25.09,12/11/2013,"In-kind items and services",221922152,"Food and Beverage","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,23.7,04/09/2014,"In-kind items and services",161138084,"Food and Beverage","",NovoLog,"",""
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,23.09,12/16/2013,"Cash or cash equivalent",13958788,"Food and Beverage","",BYDUREON,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,22.97,05/16/2014,"In-kind items and services",161391108,"Food and Beverage","",NovoLog,Levemir,""
46454,"Novo Nordisk Inc",NJ,100000000144,22.77,03/07/2014,"In-kind items and services",162173062,"Food and Beverage","",Victoza,"",""
46454,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,22.22,02/06/2014,"In-kind items and services",216240952,"Food and Beverage","",SAMSCA,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,21.85,12/06/2013,"In-kind items and services",221849542,"Food and Beverage","",NovoLog,"NovoLog Mix 70 30",""
46454,"Novo Nordisk Inc",NJ,100000000144,21.00,10/22/2013,"In-kind items and services",221921358,"Food and Beverage","",Victoza,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,20.92,08/15/2014,"In-kind items and services",150784116,"Food and Beverage","",BYDUREON,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,20.92,08/15/2014,"In-kind items and services",150823608,"Food and Beverage","",BYDUREON,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,20.92,08/15/2014,"In-kind items and services",150765130,"Food and Beverage","",BYDUREON,"","Speaker Expenses"
46454,"Eisai Inc.",NJ,100000000136,20.7,05/12/2014,"Cash or cash equivalent",184465006,"Food and Beverage","",Belviq,"",""
46454,"Eisai Inc.",NJ,100000000136,19.67,03/03/2014,"Cash or cash equivalent",184465012,"Food and Beverage","",Belviq,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,19.67,10/16/2014,"In-kind items and services",150176094,"Food and Beverage","","BYDUREON WEEKLY","","Speaker Expenses"
46454,"Medtronic MiniMed, Inc.",MN,100000010391,19.65,03/27/2014,"In-kind items and services",152104180,"Food and Beverage","","","",""
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.58,12/13/2013,"Cash or cash equivalent",13958789,"Food and Beverage","",BYDUREON,"",""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,19.55,06/24/2014,"In-kind items and services",188687902,"Food and Beverage","",LANTUS,"",""
46454,"Pfizer Inc.",NY,100000000286,19.49,08/26/2013,"In-kind items and services",206011940,"Food and Beverage","","","",""
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.36,10/30/2013,"Cash or cash equivalent",13958786,"Food and Beverage","",BYDUREON,"",""
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.28,09/10/2013,"Cash or cash equivalent",13958785,"Food and Beverage","",BYDUREON,"",""
46454,"LILLY USA, LLC",IN,100000000066,18.65,08/21/2013,"In-kind items and services",100105802,"Food and Beverage","",HUMALOG,TRADJENTA,""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,18.5,06/16/2014,"In-kind items and services",148850374,"Food and Beverage","",BYDUREON,"","Informational Meal"
46454,"Novo Nordisk Inc",NJ,100000000144,18.05,12/06/2013,"In-kind items and services",221922122,"Food and Beverage","",Victoza,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,18.03,04/10/2014,"In-kind items and services",148579228,"Food and Beverage","",BYDUREON,"","Educational Program"
46454,"Novo Nordisk Inc",NJ,100000000144,17.73,12/12/2014,"In-kind items and services",162370236,"Food and Beverage","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,17.7,06/09/2014,"In-kind items and services",161417720,"Food and Beverage","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,17.66,02/04/2014,"In-kind items and services",160698420,"Food and Beverage","","","",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,17.24,01/25/2014,"In-kind items and services",149319745,"Food and Beverage","",BYDUREON,"","Speaker Expenses"
46454,"LifeScan, Inc.",PA,100000005709,16.95,08/08/2013,"In-kind items and services",10358069,"Food and Beverage","",Invokana,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,16.91,07/01/2014,"In-kind items and services",161558982,"Food and Beverage","",NovoLog,Levemir,""
46454,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,16.63,01/09/2014,"In-kind items and services",194224269,"Food and Beverage","",Oseni,Kazano,""
46454,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,16.55,06/05/2014,"In-kind items and services",196367318,"Food and Beverage","",PRADAXA,SPIRIVA,""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,16.47,09/23/2014,"In-kind items and services",188799382,"Food and Beverage","","","",""
46454,"Novo Nordisk Inc",NJ,100000000144,16.35,08/19/2014,"In-kind items and services",161836023,"Food and Beverage","",Victoza,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.32,03/26/2014,"In-kind items and services",148717248,"Food and Beverage","",FARXIGA,"","Educational Program"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.22,12/16/2014,"In-kind items and services",150651100,"Food and Beverage","","BYDUREON WEEKLY","","Informational Meal"
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,16,07/30/2014,"In-kind items and services",188816730,"Food and Beverage","",LANTUS,"",""
46454,"Abbott Laboratories",IL,100000010680,15.44,08/29/2013,"In-kind items and services",102315302,"Food and Beverage","","","",""
46454,"Novo Nordisk Inc",NJ,100000000144,15.27,03/05/2014,"In-kind items and services",160943184,"Food and Beverage","",Levemir,Victoza,""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.22,10/16/2014,"In-kind items and services",149720344,"Food and Beverage","","","","Speaker Expenses"
46454,"Pfizer Inc.",NY,100000000286,15.1,09/18/2014,"In-kind items and services",205990420,"Food and Beverage","",LYRICA,"",""
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,14.86,01/27/2014,"Cash or cash equivalent",187744328,"Food and Beverage","",BYDUREON,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,14.77,12/05/2014,"In-kind items and services",162399926,"Food and Beverage","",Levemir,NovoLog,""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.74,09/17/2014,"In-kind items and services",148391508,"Food and Beverage","","","","Informational Meal"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.73,03/17/2014,"In-kind items and services",149556202,"Food and Beverage","",BYDUREON,"","Informational Meal"
46454,"Novo Nordisk Inc",NJ,100000000144,14.69,10/08/2014,"In-kind items and services",162317702,"Food and Beverage","",Levemir,NovoLog,""
46454,"Novo Nordisk Inc",NJ,100000000144,14.58,12/17/2013,"In-kind items and services",221853289,"Food and Beverage","",Levemir,NovoLog,""
46454,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,14.55,08/06/2013,"In-kind items and services",103297054,"Food and Beverage","",Oseni,Kazano,""
46454,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.49,11/18/2014,"In-kind items and services",196367316,"Food and Beverage","",JARDIANCE,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,14.42,07/29/2014,"In-kind items and services",161788212,"Food and Beverage","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,14.34,06/27/2014,"In-kind items and services",161691052,"Food and Beverage","",Victoza,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.29,02/19/2014,"In-kind items and services",150777852,"Food and Beverage","",BYDUREON,"","Educational Program"
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,14.28,08/15/2013,"In-kind items and services",14255503,"Food and Beverage","",APIDRA,LANTUS,""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.25,11/19/2014,"In-kind items and services",148413178,"Food and Beverage","","","","Speaker Expenses"
46454,"LILLY USA, LLC",IN,100000000066,14.01,09/30/2014,"In-kind items and services",137867242,"Food and Beverage","",HUMALOG,"",""
46454,"LILLY USA, LLC",IN,100000000066,13.91,10/22/2013,"In-kind items and services",100014192,"Food and Beverage","",TRADJENTA,HUMALOG,""
46454,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,13.88,08/14/2014,"In-kind items and services",194224206,"Food and Beverage","",Nesina,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,13.53,08/14/2014,"In-kind items and services",161882330,"Food and Beverage","",Levemir,NovoLog,""
46454,"Novo Nordisk Inc",NJ,100000000144,13.21,06/03/2014,"In-kind items and services",161634622,"Food and Beverage","","","",""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,13.21,08/19/2014,"In-kind items and services",188816740,"Food and Beverage","",LANTUS,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,13.19,09/11/2013,"In-kind items and services",221887850,"Food and Beverage","",Levemir,NovoLog,""
46454,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.18,11/14/2013,"In-kind items and services",104378834,"Food and Beverage","",TRADJENTA,"",""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,13.15,12/15/2014,"In-kind items and services",188869614,"Food and Beverage","",LANTUS,"",""
46454,"GlaxoSmithKline, LLC.",NC,100000005449,13.14,08/05/2014,"In-kind items and services",198760662,"Food and Beverage","",TANZEUM,"",""
46454,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.86,11/21/2013,"In-kind items and services",23817242,"Food and Beverage","",Invokana,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,12.84,06/20/2014,"In-kind items and services",161576999,"Food and Beverage","",NovoLog,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,12.84,03/14/2014,"In-kind items and services",161213166,"Food and Beverage","",Victoza,"",""
46454,"Medtronic MiniMed, Inc.",MN,100000010391,12.78,05/20/2014,"In-kind items and services",152095830,"Food and Beverage","","","",""
46454,"Novo Nordisk Inc",NJ,100000000144,12.76,09/03/2014,"In-kind items and services",162094124,"Food and Beverage","",Levemir,NovoLog,""
46454,"LILLY USA, LLC",IN,100000000066,12.65,03/27/2014,"In-kind items and services",137562754,"Food and Beverage","",HUMALOG,TRADJENTA,""
46454,"Eisai Inc.",NJ,100000000136,12.58,12/03/2013,"Cash or cash equivalent",152462092,"Food and Beverage","",Belviq,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,12.57,12/02/2014,"In-kind items and services",162217130,"Food and Beverage","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,12.54,08/09/2013,"In-kind items and services",221950086,"Food and Beverage","",Victoza,"",""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.07,10/06/2014,"In-kind items and services",188878856,"Food and Beverage","",LANTUS,"",""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.03,03/31/2014,"In-kind items and services",188557144,"Food and Beverage","",LANTUS,"",""
46454,"LILLY USA, LLC",IN,100000000066,11.97,11/12/2013,"In-kind items and services",100167764,"Food and Beverage","",HUMULIN,"",""
46454,"VIVUS, Inc.",CA,100000005620,11.93,08/12/2013,"Cash or cash equivalent",27276635,"Food and Beverage","",Qsymia,"",""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.78,07/28/2014,"In-kind items and services",188708302,"Food and Beverage","",LANTUS,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.76,11/06/2014,"In-kind items and services",150766440,"Food and Beverage","","BYDUREON WEEKLY","","Speaker Expenses"
46454,"Novo Nordisk Inc",NJ,100000000144,11.69,04/24/2014,"In-kind items and services",162217094,"Food and Beverage","",Levemir,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,11.48,03/14/2014,"In-kind items and services",162044656,"Food and Beverage","",Levemir,"",""
46454,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,11.46,12/19/2013,"Cash or cash equivalent",13958784,"Food and Beverage","",BYDUREON,"",""
46454,"LILLY USA, LLC",IN,100000000066,11.46,11/25/2014,"In-kind items and services",137907254,"Food and Beverage","",TRULICITY,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,11.23,11/25/2013,"In-kind items and services",221920328,"Food and Beverage","",Victoza,"",""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.20,09/30/2013,"In-kind items and services",14263941,"Food and Beverage","",LANTUS,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.01,05/27/2014,"In-kind items and services",150873310,"Food and Beverage","","","","Informational Meal"
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,10.84,01/28/2014,"In-kind items and services",188636136,"Food and Beverage","",APIDRA,LANTUS,""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,10.61,06/04/2014,"In-kind items and services",188705484,"Food and Beverage","",LANTUS,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,10.4,04/29/2014,"In-kind items and services",161305234,"Food and Beverage","",Victoza,Levemir,""
46454,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.32,07/07/2014,"In-kind items and services",194224278,"Food and Beverage","",Oseni,Kazano,""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.23,08/11/2014,"In-kind items and services",148320422,"Food and Beverage","","","","Informational Meal"
46454,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.13,02/18/2014,"In-kind items and services",156467782,"Food and Beverage","",Invokana,"",""
46454,"LifeScan, Inc.",PA,100000005709,9.74,10/23/2013,"In-kind items and services",10360313,"Food and Beverage","",Invokana,"",""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.58,05/28/2014,"In-kind items and services",188516420,"Food and Beverage","",APIDRA,LANTUS,""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.47,06/23/2014,"In-kind items and services",188687900,"Food and Beverage","",LANTUS,"",""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.42,10/27/2014,"In-kind items and services",188803648,"Food and Beverage","",LANTUS,"",""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.05,03/28/2014,"In-kind items and services",188542000,"Food and Beverage","",LANTUS,APIDRA,""
46454,"Novo Nordisk Inc",NJ,100000000144,8.85,02/12/2014,"In-kind items and services",160898388,"Food and Beverage","",Levemir,NovoLog,""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,8.83,01/13/2014,"In-kind items and services",150104990,"Food and Beverage","","BYDUREON WEEKLY","","Informational Meal"
46454,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.77,11/04/2014,"In-kind items and services",156467792,"Food and Beverage","","","",""
46454,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.49,09/04/2014,"In-kind items and services",156467784,"Food and Beverage","",Invokana,"",""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,8.27,08/05/2013,"In-kind items and services",14278801,"Food and Beverage","",GLARGINE,LIXISENATIDE,""
46454,"Novo Nordisk Inc",NJ,100000000144,8.09,09/24/2013,"In-kind items and services",221941096,"Food and Beverage","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,7.64,11/04/2013,"In-kind items and services",221922788,"Food and Beverage","",Victoza,"",""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,7.26,05/19/2014,"In-kind items and services",188645848,"Food and Beverage","",LANTUS,"",""
46454,"VIVUS, Inc.",CA,100000005620,6.81,10/14/2013,"Cash or cash equivalent",27276638,"Food and Beverage","",Qsymia,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,6.72,11/13/2014,"In-kind items and services",160626620,"Travel and Lodging","",Victoza,"",""
46454,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,5.83,08/16/2013,"In-kind items and services",103297058,"Food and Beverage","",Oseni,Kazano,""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,5.04,09/29/2014,"In-kind items and services",149959352,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"Janssen Pharmaceuticals, Inc",NJ,100000000232,5.02,10/10/2014,"In-kind items and services",156467790,Education,"",Invokana,"","Journal Article"
46454,"Janssen Pharmaceuticals, Inc",NJ,100000000232,5.02,09/17/2014,"In-kind items and services",156467788,Education,"",Invokana,"","Journal Article"
46454,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,4.97,10/08/2013,"In-kind items and services",103297056,"Food and Beverage","",Oseni,Kazano,""
46454,"Novo Nordisk Inc",NJ,100000000144,4.51,02/20/2014,"In-kind items and services",160614608,Education,"",NovoLog,"",""
46454,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,4.32,08/06/2014,"In-kind items and services",194224284,"Food and Beverage","",Kazano,Oseni,""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,4.21,04/09/2014,"In-kind items and services",148583108,"Food and Beverage","","","","Speaker Expenses"
46454,"Novo Nordisk Inc",NJ,100000000144,3.39,12/11/2013,"In-kind items and services",221922118,"Travel and Lodging","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,3.36,12/03/2014,"In-kind items and services",160625930,"Travel and Lodging","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,2.8,09/18/2014,"In-kind items and services",160621086,"Travel and Lodging","",NovoLog,"",""
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,2.24,04/22/2014,"In-kind items and services",149051214,"Travel and Lodging","",FARXIGA,"","Speaker Expenses"
46454,"AstraZeneca Pharmaceuticals LP",DE,100000000146,2.24,12/19/2014,"In-kind items and services",148453698,"Travel and Lodging","",BYDUREON,"","Speaker Expenses"
46454,"Novo Nordisk Inc",NJ,100000000144,2.22,09/24/2013,"In-kind items and services",221941086,"Food and Beverage","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,1.91,12/05/2013,"In-kind items and services",221849544,"Food and Beverage","",NovoLog,"NovoLog Mix 70 30",""
46454,"Novo Nordisk Inc",NJ,100000000144,1.89,06/09/2014,"In-kind items and services",161417732,"Food and Beverage","",Victoza,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,1.69,11/04/2013,"In-kind items and services",221922786,"Food and Beverage","",Victoza,"",""
46454,"Janssen Pharmaceuticals, Inc",NJ,100000000232,1.38,09/04/2014,"In-kind items and services",156467786,Education,"",Invokana,"","Journal Article"
46454,"Novo Nordisk Inc",NJ,100000000144,1.18,09/11/2013,"In-kind items and services",221887848,"Food and Beverage","",Levemir,NovoLog,""
46454,"Novo Nordisk Inc",NJ,100000000144,1.17,05/15/2014,"In-kind items and services",161391110,"Food and Beverage","",Levemir,NovoLog,""
46454,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,1.02,09/30/2013,"In-kind items and services",14263942,"Food and Beverage","",LANTUS,"",""
46454,"LILLY USA, LLC",IN,100000000066,0.75,11/12/2013,"In-kind items and services",100167778,"Food and Beverage","",HUMULIN,"",""
46454,"Novo Nordisk Inc",NJ,100000000144,0.56,08/13/2014,"In-kind items and services",161888500,"Food and Beverage","",Levemir,NovoLog,""
46454,"Novo Nordisk Inc",NJ,100000000144,0.47,12/05/2014,"In-kind items and services",162400586,"Food and Beverage","",Levemir,NovoLog,""
46454,"Novo Nordisk Inc",NJ,100000000144,0.33,06/30/2014,"In-kind items and services",162434954,"Food and Beverage","",NovoLog,Levemir,""
46454,"Novo Nordisk Inc",NJ,100000000144,0.18,08/18/2014,"In-kind items and services",161836012,"Food and Beverage","",Victoza,"",""
